Literature DB >> 17047132

A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin.

T Watanabe, M Inoue, K Harada, N Homma, M Uchida, N Ogata, R Funada, K Hasegawa, K Soga, K Shibasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17047132      PMCID： PMC1860123          DOI： 10.1136/gut.2006.105197

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Ulcerative colitis associated with interferon treatment for chronic hepatitis C.

Authors:  C Mavrogiannis; I S Papanikolaou; I S Elefsiniotis; D I Psilopoulos; A Karameris; G Karvountzis
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

Review 2.  [A case of ulcerative colitis along with characteristic features on computed tomography (CT), developed by the treatment with interferon for chronic hepatitis C].

Authors:  T Niki; K Nishida; Y Honsako; Y Matsumura; H Ueno; T Fujimi; T Sashikata
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2001-04

Review 3.  [A case of acute phase ulcerative colitis like colitis developed by the interferon-beta therapy for chronic hepatitis C].

Authors:  Teruhito Awakawa; Sae Hirohashi; Kimiko Hasegawa; Hiroyuki Tsukuda; Yumiko Ibayashi; Toshimitsu Hirane; Takeaki Kobayashi; Eiichi Bekki; Kohzoh Imai
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2003-06

4.  Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.

Authors:  R Sprenger; M Sagmeister; F Offner
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  [Exacerbation of ulcerative colitis and chronic hepatitis by the treatment with interferon for chronic hepatitis B].

Authors:  K Yasumori; T Aramaki; Y Mizuta; T Nomoto; N Mukai; Y Tanaka
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1995-07

6.  [Interferon induced IBD-like acute colitis--two cases of patients with chronic active hepatitis].

Authors:  Y Yamamoto; N Sakatani; S Yano; K Kou; S Ochi; Y Yoshida; R Fujimoto; K Ohno; S Sawai
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1995-09

7.  Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.

Authors:  Q Ning; D Brown; J Parodo; M Cattral; R Gorczynski; E Cole; L Fung; J W Ding; M F Liu; O Rotstein; M J Phillips; G Levy
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

8.  Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C.

Authors:  A Mitoro; M Yoshikawa; K Yamamoto; M Mimura; Y Yoshikawa; A Shiroi; T Mochi; T Sakamoto; J Yamao; E Kikuchi
Journal:  Intern Med       Date:  1993-04       Impact factor: 1.271
  8 in total
  15 in total

Review 1.  Immunomodulatory functions of type I interferons.

Authors:  José M González-Navajas; Jongdae Lee; Michael David; Eyal Raz
Journal:  Nat Rev Immunol       Date:  2012-01-06       Impact factor: 53.106

2.  Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis.

Authors:  Jay Luther; Stephanie Y Owyang; Tomomi Takeuchi; Tyler S Cole; Min Zhang; Maochang Liu; John Erb-Downward; Joel H Rubenstein; Chun-Chia Chen; Anna V Pierzchala; Jose A Paul; John Y Kao
Journal:  Gut       Date:  2011-04-06       Impact factor: 23.059

3.  Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.

Authors:  Adelle P McFarland; Ram Savan; Sagie Wagage; Augustina Addison; Karthika Ramakrishnan; Megan Karwan; Tri Duong; Howard A Young
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

4.  Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection.

Authors:  Ji Hun Kim; Jeong Won Jang; Chan Ran You; Si Young You; Mun Kyung Jung; Jin Hwan Jung
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

5.  Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.

Authors:  Eckart Schott; Friedemann Paul; Jens T Wuerfel; Frauke Zipp; Birgit Rudolph; Bertram Wiedenmann; Daniel C Baumgart
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

6.  Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.

Authors:  Alina M Allen; W Ray Kim; Joseph Larson; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

Review 7.  Hepatitis C virus and inflammatory bowel disease.

Authors:  Todd L Horn; Joel Reynolds; Willem de Villiers; Luis R Peña
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

8.  Interferon-Induced Crohn's Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection.

Authors:  Omer Basar; Francis Dailey; Erica Dailey; Veysel Tahan; Ebubekir Daglilar
Journal:  Cureus       Date:  2021-06-10

9.  Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?

Authors:  Heiko Mühl
Journal:  Front Immunol       Date:  2013-02-04       Impact factor: 7.561

Review 10.  Type I interferons for induction of remission in ulcerative colitis.

Authors:  Yongjun Wang; John K MacDonald; Eric I Benchimol; Anne Marie Griffiths; A Hillary Steinhart; Remo Panaccione; Cynthia H Seow
Journal:  Cochrane Database Syst Rev       Date:  2015-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.